Patent · US Active

Cyclic peptides multimers targeting α-4-β-7 integrin

US11713338B2 · kind B2 · utility

1Cited by
14References
39Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 19, 2021
Grant dateAug 1, 2023
Priority date
Expiry dateApr 19, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is described herein, multimers comprising a plurality of compounds covalently linked together, the compounds independently being of formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.